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Summary 
 
Cerebrovascular pathology in diabetic patients is associated with focal and diffuse 
cerebral lesions. Though structural brain abnormalities are not diabetes-specific, they 
are indicative of prognostication of developing cerebral blood circulation impairment 
in diabetics. Since pathogenesis of diabetic encephalopathy and its clinical-diagnostic 
manifestation depends on the type of diabetes mellitus, present investigation concerns 
differential peculiarities of diffuse and focal brain abnormalities in patients with 
diabetic encephalopathy depending on diabetes type. Influenced by the type of basic 
disease, neuroimaging data of focal brain abnormalities in patients with diabetic 
encephalopathy require differential diagnostic and therapeutic approach. 
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The prevalence of diabetes mellitus (DM) world-wide amounts to 240 million patients and it is 
expected to rise to 330 or even 500 million by the year 2030 [4]. Diabetic encephalopathy (DE), 
remaining the least studied chronic complication of DM, is considered to be cerebrovascular 
pathology, associated with focal and diffuse cerebral lesions [1, 2, 5]. Accompanied with metabolic 
derangements, cerebrovascular abnormalities and repeated severe hypoglycaemic episodes, 
kethoacidotic conditions have been implicated to create a unique clinical-diagnostic manifestation 
of DE [7, 9].  
 
Being not diabetes-specific, structural brain abnormalities are indicative of detection of diabetic 
angiopathy and prognostication of developing cerebral blood circulation impairment [3]. 
Neuroimaging studies commonly reveal multiple small focal lesions, generally of periventricular 
localization, frequently followed by cortical atrophy and enlargement of the cerebral ventricles [3, 
6, 8, 10-13].  
 
Recent studies have reported an association between these changes and the patients’ age [12, 13], 
severity of diabetes [3], neurological performance [6], and those neurovisual indices correlated with 
cognitive deficiency degree in DE patients [8, 10, 13]. Furthermore, due to the difference in 
pathogenesis of DE in various types of DM, further additional investigation is necessary concerning 
diffuse and focal brain abnormalities depending on diabetes type.  
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Materials and Methods 
 
Objective of the research was to reveal differential peculiarities of diffuse and focal brain 
abnormalities in DE patients (42 cases of DE were analyzed) depending on the type of DM. 12 
healthy individuals served as control group. Examination of macrostructural brain abnormalities 
were performed using magnetic resonance imager (MRI) Siemens Magnetom Impakt and computer 
tomographic (CT) scanner Siemens Somatom-crx.  
 
 
Results and Discussion 
 
Linear parameters of the brain lateral ventricles were found to undergo the most substantial changes 
in both type 1 and type 2 diabetic patients with DE (fig.1). 
 
    
Fig. 1. Enlargement of the lateral ventricles in patients with diabetic encephalopathy 
 
 
Thus, the width of their frontal horns was increased dramatically (Table 1) by 35,9 and 64,1 % in 
type 1 and 2 DM respectively (high statistical significance was found – Р<0,001).  
 
It should be noted, that the most marked extension (by 12,3%, Р<0,05) was observed in type 1 
diabetes with DE. Significant enlargement of these right-sided parameters was also demonstrated in 
DM of both types (by 43,5 and 66,1% respectively, Р<0,001). The index of the frontal horns of 
lateral ventricles in type 1 diabetics with DE was 12,3% higher as compared with that in controls 
(Р<0,05). Its increase in type 2 DM was more considerable than in the group of type 1 diabetics (by 
13,8%, Р<0,05), exceeding that of the controls by 27,8 % (Р<0,001).  
 
Absolute transversal sizes of the central regions of lateral ventricles increased in case of DM type 1 
(by 45,4% on the left and by 48,6% – on the right, Р<0,001) as well as in DM type 2 (by 66,7 and 
64,4 % respectively, Р<0,001).  
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Таble 1. Linear parameters and indices of the brain ventricles in patients with diabetic encephalopathy 
 
Linear parameters and indices of the brain ventricles 
(mm) 
Controls 
(n=12) 
Type 1 
diabetics with 
DE  
(n=13) 
Type 2 
diabetics with 
DE  
(n=29) 
Index of the frontal horns of lateral ventricles 25,2±1,18 28,3±0,94 
Р1<0,05 
32,2±1,10 
Р1<0,001 
Р2<0,05 
Width of the frontal horns of lateral ventricles, mm    
• on the left 6,4±0,19 8,7±0,43 
Р1<0,001 
10,5±0,48 
Р1<0,001 
Р2<0,05 
• on the right 6,2±0,21 8,9±0,56 
Р1<0,001 
10,3±0,42 
Р1<0,001 
Р2>0,05 
Index of the central regions of lateral ventricles 24,6±0,86 27,7±1,08 
Р1<0,05 
29,6±0,73 
Р1<0,001 
Р2>0,05 
Width of the central regions of lateral ventricles, mm    
• on the left 10,8±0,37 15,7±0,80 
Р1<0,001 
18,0±0,52 
Р1<0,001 
Р2<0,05 
• on the right 10,7±0,33 15,9±0,83 
Р1<0,001 
17,7±0,49 
Р1<0,001 
Р2<0,05 
Index of the occipital horns of lateral ventricles 37,0±0,72 41,3±1,28 
Р1<0,01 
45,7±1,2 
Р1<0,001 
Р2<0,05 
Width of the occipital horns of lateral ventricles, mm    
• on the left 10,2±0,42 13,2±0,93 
Р1<0,01 
15,1±0,60 
Р1<0,001 
Р2>0,05 
• on the right 9,8±0,42 12,5±0,78 
Р1<0,01 
14,4±052 
Р1<0,001 
Р2<0,05 
Іndex of 3rd ventricle  4,2±0,15 6,6±0,36 
Р1<0,001 
7,4±0,31 
Р1<0,001 
Р2>0,05 
Width of 3rd ventricle, mm 3,9±0,15 6,1±0,40 
Р1<0,001 
6,9±0,24 
Р1<0,001 
Р2>0,05 
Іndex of 4th ventricle 13,2±0,44 14,9±0,74 
Р1>0,05 
15,2±0,52 
Р10,05 
Р2>0,05 
Width of 4th ventricle, mm 11,2±0,30 11,2±0,44 
Р1>0,05 
12,1±0,48 
Р1>0,05 
Р2>0,05 
Note: values are expressed as means ± standard errors; 
Р1 – significant difference in comparison with control (Р≤0,05);  
Р2 – significant difference in comparison between groups of the patients with type 1 and type 2 DM (Р≤0,05).  
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This widening was more significant (Р<0,05) in non-insulin-dependent DM than in insulin-
dependent one, however the elevation of index of the central regions of lateral ventricles in DE was 
lower (by 12,6% in type 1 DM, Р<0,05, and by 20,3% in type 2 DM, Р<0,001) and didn’t 
significantly differ among studied groups. The occipital horns of lateral ventricles in type 1 
diabetics with DE were enlarged on the left (by 29,4%, Р<0,01) as well as on the right (by 48,4%, 
Р<0,01). In type 2 DM the expansion of these structures was more noticeable (by 48,0 and 46,9% 
respectively, Р<0,001), exceeding the corresponding right-sided index in the group of type 1 
diabetics by 15,2% (Р<0,05). The occipital horns index also increased concerning the controls in 
both type 1 (by 11,6%, Р<0,01) and type 2 diabetes (by 23,5%, Р<0,0001), moreover in case of 
non-insulin-dependent DM this index was significantly higher than in insulin-dependent DM (by 
10,7%, Р<0,05). Thus, the signs of internal hydrocephaly were observed in patients with DE, more 
evident in type 2 DM. 
 
The extension of the subarachnoid spaces in patients with DE was also observed in the present 
research (fig. 2).  
 
 
Fig. 2. Signs of hydrocephaly in patient with diabetic encephalopathy 
 
The significant enlargement of lateral fissure maximal width (Table 2) was found from its posterior 
regions on the same level as the pineal body in patients with DE in both type 1 (by 53,5% on the 
left, by 61,0% – on the right, Р<0,001) and type 2 DM (by 69,8% on the left, by 70,7% – on the 
right, Р<0,001). No statistically significant between-group differences were noted.  
 
Maximal width of anterior regions of interhemispheric fissure also increased in case of DE (by 
41,0% in type 1 DM (Р<0,01) and by 59,0% in type 2 DM (Р<0,001)). Central sulcus width also 
significantly enlarged, although not as markedly as previous parameter (by 18,8% in insulin-
dependent DM and by 28,1% in non-insulin-dependent DM). 
 
According to the brain CT scans above the level of lateral ventricles the number of fissures on 
conveccital surfaces of cerebral hemispheres significantly increased by 21,5% in type 2 diabetics 
with DE and no statistically significant changes were observed in type 1 diabetics and control 
individuals.  
 
The extension of ventricular system and subarachnoid spaces in case of DE was indicative of 
cerebral atrophy. It is obvious, that signs of ventricular hydrocephaly in patients with DE prevailed 
in comparison with the degree of cortical fissures extension, signifying not only the decreased 
amount of cerebral white matter in the profound regions of the brain, but also indicating connection 
with the depression of periventricular tissues resistance towards liquor-dynamic processes.             
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In addition, the tendency of left-sided prevalence of both external and internal hydrocephaly was 
noticed.  
 
Таble 2. Subarachnoid spaces ratios in patients with diabetic encephalopathy 
 
Linear parameters and indices of the brain 
ventricles (mm) 
Controls 
(n=12) 
Type 1 
diabetics with 
DE  
(n=13) 
Type 2 
diabetics with 
DE  
(n=29) 
Sylvian fissure maximal width (from its posterior 
region), mm 
   
• on the left 4,3±0,28 6,6±0,46 
Р1<0,001 
 
7,3±0,26 
Р1<0,001 
Р2>0,05 
• on the right 4,1±0,26 6,6±0,43 
Р1<0,001 
7,0±0,25 
Р1<0,001 
Р2>0,05 
Interhemispheric fissure maximal width (from its 
anterior region), mm 
3,9±0,31 5,5±0,37 
Р1<0,01 
 
6,2±0,25 
Р1<0,001 
Р2>0,05 
Central sulcus width, mm 3,2±0,17 3,8±0,23 
Р1<0,05 
4,1±0,18 
Р1<0,01 
Р2>0,05 
Number of fissures above the bodies of lateral 
ventricles 
20,0±0,16 22,3±1,51 
Р1>0,05 
24,3±0,99 
Р1<0,05 
Р2>0,05 
Note: values are expressed as means ± standard errors; 
Р1 – significant difference in comparison with control (Р≤0,05);  
Р2 – significant difference in comparison between groups of type 1 and type 2 diabetics (Р≤0,05). 
 
Significantly more substantial changes of linear parameters and indices of the ventricles in patients 
with type 2 DM as compared with those in type 1 diabetics reflects more severe cerebral atrophy 
and internal hydrocephaly in case of non-insulin-dependent DM. Furthermore, the changes of 
subarachnoid spaces ratios in case of DE tend to be equal in both insulin-dependent and non-
insulin-dependent DM.  
 
The investigation of structural peculiarities of the cerebral white matter allowed to detect the focal 
lesions, mostly left-sided, in 81,0% of patients with DE. The incidence of lesions was equal in DM 
of both types. Singular or multiple foci, less than 15 mm in diameter, of small lacunar infarctions of 
the white matter and subcortical ganglia, localized mostly periventricularly, in the areas of small 
vessels most sensitive to the of hemodymanic disorders, prevailed in neurovisual data of patients 
with DE (fig.3). At the same time, in type 2 diabetics with DE there were mostly singular, rarely – 
multiple small lesions, 15 mm in diameter, and in DM type 1 multiple small lesions, sized less than 
15 mm, were more frequent. These small spots on MRI scans, related to the expansion of Virchow-
Robin perivascular spaces, may be considered as the manifestation of diabetic cerebral 
microangiopathy. Focal lesions of various localization, sized over 15 mm, were more incidental in 
insulin-dependent DM as compared with non-insulin-dependent DM (fig. 4). The majority of 
lesions were located in basal ganglia, thalamus and subcortical white matter, rarely – in cerebral 
cortex and midbrain. In 69,0% cases of DE, diffuse or focal bilateral white matter lesions of low 
density of periventricular cortex by CT or high-intensities distributed around the bodies of lateral 
ventricles (fig. 5) and scored as leukoaraiosis (“periventricular shining”) by T2-weighted MRI were 
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also observed, being limited in 33,3% cases either by anterior or posterior regions of the ventricles 
and in 28,6% cases – by anterior as well as posterior ones; in 7,1% cases unlimited periventricular 
transparency was revealed.  
 
 
Fig. 3. Multiple white matter lesions in patient with diabetic encephalopathy 
 
 
  
Fig. 4. Focal white matter lesions, over 15 mm in diameter, in patients with diabetic 
encephalopathy 
 
 
  
Fig. 5. Signs of leukoaraiosis in patient with diabetic encephalopathy 
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Thus, imaging data of focal brain abnormalities in patients with DE depend on the type of basic 
disease, indicating to different pathogenical mechanisms of this pathological condition, and require 
differential diagnostic and therapeutic approach. 
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